Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -13,212 | -8,118 | -4,431 | -12,436 |
| Depreciation Amortization | 10 | 2 | -6 | -115 |
| Accounts payable and accrued liabilities | 20 | 934 | 36 | N/A |
| Other Working Capital | -187 | 552 | -102 | -1,020 |
| Other Operating Activity | 244 | -754 | 56 | 1,061 |
| Operating Cash Flow | $-13,125 | $-7,384 | $-4,447 | $-12,510 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 7,400 | 6,200 | 5,200 | N/A |
| PPE Investments | -8 | -1 | -1 | -7 |
| Other Investing Activity | 0 | 0 | 0 | -7,234 |
| Investing Cash Flow | $7,392 | $6,199 | $5,199 | $-7,241 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 77 | 26 | 26 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 24,986 |
| Financing Cash Flow | $77 | $26 | $26 | $24,986 |
| Beginning Cash Position | 17,501 | 17,501 | 17,501 | 12,266 |
| End Cash Position | 11,845 | 16,342 | 18,279 | 17,501 |
| Net Cash Flow | $-5,656 | $-1,159 | $778 | $5,235 |
| Free Cash Flow | ||||
| Operating Cash Flow | -13,125 | -7,384 | -4,447 | -12,510 |
| Capital Expenditure | -8 | -1 | -1 | N/A |
| Free Cash Flow | -13,133 | -7,385 | -4,448 | -12,510 |